Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting - Quiz - MDSpire

Subepithelial Myofibroblasts in the Intestine and Their Role in Inflammatory Bowel Disease: Exploring Fibroblast Diversity, Fibrosis, and Potential Therapeutic Approaches

By
Fang Li
Chao Xu
Jun Chen
Teng Lei
Xigui Tian
Yuanling Zhang
Guoqing Chen
June 24, 2026

Frontiers In Medicine

Share

Original Source(s)

Frontiers In Medicine

Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting

by Fang Li, Chao Xu, Jun Chen, Teng Lei, Xigui Tian, Yuanling Zhang, Guoqing Chen
June 24, 2026

Related Content

Frontiers In Immunology

Microbiota metabolite butyrate alleviates intestinal inflammation associated with enhanced autophagy-related signaling in DSS-induced colitis

by Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yue Lei, Zhou Zhang, Mengque Xu
June 17, 2026

Frontiers In Immunology

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

Gut

Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study